Related Experiment Video
Updated: Jul 15, 2026

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
Published on: March 14, 2017
The pathophysiology, prevention, and treatment of stroke in sickle cell disease
1Department of Hematology, St Jude Children's Research Hospital, Memphis, TN 38105, USA. winfred.wang@stjude.org
Insights
Advances in sickle cell disease research offer new stroke prevention strategies. Transcranial Doppler screening improves primary stroke prevention, while hydroxyurea shows promise for secondary stroke prevention, potentially reducing reliance on transfusions.
Area of Science:
- Neurology
- Hematology
- Vascular Medicine
Background:
- Stroke is a major complication of sickle cell disease (SCD).
- Recent research has enhanced understanding of SCD-related central nervous system (CNS) events.
- New approaches for primary and secondary stroke prevention are emerging.
Purpose of the Study:
- To review recent advances in the understanding and prevention of stroke in SCD.
- To highlight new insights into the pathogenesis of CNS complications in SCD.
- To discuss novel strategies for primary and secondary stroke prevention.
Main Methods:
- Review of recent scientific literature (past 2 years) on SCD and stroke.
- Analysis of emerging concepts in SCD pathophysiology, including hemolytic anemia and nitric oxide metabolism.
- Evaluation of current and investigational stroke prevention strategies.
Main Results:
- Pathophysiology insights focus on hemolytic anemia, nitric oxide metabolism, and genetic risk factors.
- Transcranial Doppler (TCD) ultrasonography shows significant potential for primary stroke prevention, though utilization is suboptimal.
- Hydroxyurea is being investigated as an alternative to chronic transfusion for secondary stroke prevention.
- Research is also addressing silent infarcts and nocturnal hypoxemia management.
Conclusions:
- Enhanced understanding of stroke etiology in SCD will improve CNS complication management.
- Hydroxyurea offers a potential alternative to lifelong transfusions for secondary stroke prevention.
- Widespread TCD screening could dramatically reduce stroke incidence in SCD patients.
Purpose Of Review:
Stroke is one of the most devastating complications of sickle cell disease, but current research has led to improved understanding of its pathogenesis and to new approaches in the prevention of both primary and secondary stroke. This review focuses on advances reported in the past 2 years.
Recent Findings:
New concepts in the pathophysiology of central nervous system events in sickle cell disease have centered around hemolytic anemia and nitric oxide metabolism. Genetic risk factors are now being explored. Major improvement in primary stroke prevention has occurred through transcranial Doppler ultrasonography screening, but utilization of this technique is far from optimal. Hydroxyurea is now being tested as an alternative approach to chronic transfusion for secondary stroke prevention through a multicenter trial. Other studies are addressing the management of silent infarcts and nocturnal hypoxemia.
Summary:
Increased understanding of the etiology and pathogenesis of stroke in sickle cell disease should eventually lead to improved management of all central nervous system complications. Alternative secondary stroke prevention with hydroxyurea may allow patients to avoid dependence on life-long chronic transfusion. Primary stroke prevention through transcranial Doppler ultrasonography screening may ultimately yield a dramatic reduction in the incidence of stroke in sickle cell disease.
Related Concept Videos
Ischemic Stroke ll: Pathophysiology
Hemorrhagic Stroke ll: Pathophysiology
Ischemic Stroke l: Introduction
Hemorrhagic Stroke l: Introduction
Atherosclerosis IV: Nursing Management
Stroke: Introduction and Types
